Research
Energy balance
Bariatric surgery is an effective and durable weight-loss intervention that reduces major adverse liver outcomes (MALO) and cardiovascular events in patients with MASH, though data in advanced cirrhosis is limited.
Bariatric surgery offers significant long-term benefits for liver and heart health in MASH patients. It should be considered for eligible patients, especially when other treatments fail, despite limited data in advanced cirrhosis.
GoodQualifiesMEDIUM confidence
Bariatric surgery is an effective and durable weight-loss intervention with associated liver and cardiometabolic benefits, though data are limited in advanced liver disease... SPLENDOR retrospective study... demonstrated a significant reduction in MALO.
Why this rating
Based on retrospective studies and meta-analyses, not large RCTs in cirrhosis.
Source
Management of obesity in advanced chronic liver disease
Cyrielle Caussy et al. · JHEP Reports · 2026
DOI 10.1016/j.jhepr.2026.101749
narrative_review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Novel anti-obesity medications (AOMs), specifically GLP-1 receptor agonists like semaglutide (2.4 mg weekly), achieve >10% body weight loss and lead to MASH resolution and fibrosis regression in patients with fibrotic MASH, offering a viable alternative to lifestyle changes alone.Strong
- In patients with advanced chronic liver disease (ACLD), achieving >10% body weight loss through therapeutic lifestyle interventions significantly reduces portal hypertension and improves survival, although this magnitude of weight loss is difficult to sustain long-term.Good
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →